{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-078220","form_type":"8-K","ticker":"IMNM","cik":"0001472012","company_name":"Immunome Inc.","filed_at":"2023-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.019993+00:00","generated_at":"2026-06-13T12:38:25.272232+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Immunome posts updated investor presentation suggesting combination with Morphimmune; no deal terms disclosed","bullets":["On July 5, 2023, Immunome filed Form 8-K announcing posting of an updated investor presentation on its website.","Presentation is titled 'Morphimmune and Immunome Combined Corporate Presentation,' indicating a potential transaction.","No financial details, merger agreement, or definitive terms are provided in the filing or available exhibit text.","Filing does not include any forward-looking guidance, revenue impact, or timeline for the proposed combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-078220","json":"https://secwatch.observer/filing/0001104659-23-078220.json","markdown":"https://secwatch.observer/filing/0001104659-23-078220.md","text":"https://secwatch.observer/filing/0001104659-23-078220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923078220/0001104659-23-078220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923078220/tm2320602d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T12:38:25.272232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}